Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPC-5971 as Adjuvant Therapy in Shock Wave Lithotripsy
NCT00860093Phase 2Terminated
- Sponsor
- Mission Pharmacal Company
- Start
- Apr 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of potassium citrate + magnesium citrate in nephrolithiasis, sponsored by Mission Pharmacal Company. Started Apr 2010; status: terminated.
02
Drugs
potassium citrate + magnesium citrate
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT00860093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00860093.